Novel methoxylated flavone inhibitors of cytochrome P450 1B1 in SCC-9 human oral cancer cells

Journal of Pharmacy and Pharmacology

Volumn 59, Issue 6, 2007, Pages 857-862

  Walle, Thomas ^a,b   Walle, U Kristina ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3' METHOXYFLAVONE; 3',4' DIMETHOXYFLAVONE; 3,5,7,3',4' PENTAMETHOXYFLAVONE; 3,6 DIMETHOXYFLAVONE; 3,7 DIMETHOXYFLAVONE; 4' METHOXYFLAVONE; 5 METHOXYFLAVONE; 5,3' DIMETHOXYFLAVONE; 5,4' DIMETHOXYFLAVONE; 5,7 DIMETHOXYFLAVANONE; 5,7 DIMETHOXYFLAVONE; 5,7,3',4' TETRAMETHOXYFLAVONE; 5,7,4' TRIMETHOXYFLAVONE; 6,7 DIMETHOXYFLAVONE; 7 METHOXYFLAVONE; 7,3' DIMETHOXYFLAVONE; 7,3',4' TRIMETHOXYFLAVONE; 7,4' DIMETHOXYFLAVONE; 7,8 DIMETHOXYFLAVONE; BENZO[A]PYRENE; CURCUMIN; CYTOCHROME P450 1B1; ETHOXYRESORUFIN; FLAVONE DERIVATIVE; QUERCETIN; SINENTIN; TANGERETIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL LYSATE; CONTROLLED STUDY; CYTOTOXICITY; DIETARY INTAKE; DRUG BIOAVAILABILITY; DRUG INHIBITION; DRUG SCREENING; DRUG STRUCTURE; HUMAN; HUMAN CELL; MOUTH CANCER; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

ANALYSIS OF VARIANCE; ANTICARCINOGENIC AGENTS; ARYL HYDROCARBON HYDROXYLASES; BENZO(A)PYRENE; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; FLAVONES; FLAVONOIDS; HUMANS; MOUTH NEOPLASMS; PHENOLS; RNA, MESSENGER;

EID: 34447319174     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.59.6.0012     Document Type: Article

References (43)

1. Ahmad, F., Bakar, S. A., Ibrahim, A. Z., Read, R. W. (1997) Constituents of the leaves of Piper caninum. Planta Med. 63: 193-194
2. Cavalcante, S. H., Fernandes, D., Paulino Fo, H. F., Yoshida, M., Gottlieb, O. R. (1985) Lignoids from the fruit of three Virola species. Phytochemistry 24: 1865-1866
3. Choi, H., Chun, Y.-S., Kim, S.-W., Kim, M.-S., Park, J.-W. (2006) Curcumin inhibits hypoxia-inducible factor-1 by degrading aryl hydrocarbon receptor nuclear translocator: a mechanism of tumor growth inhibition. Mol. Pharmacol. 70: 1664-1671
4. Ciolino, H. P., Wang, T. T. Y., Yeh, G. C. (1998a) Diosmin and diosmetin are agonists of the aryl hydrocarbon receptor that differentially affect cytochrome P450 1A1 activity. Cancer Res. 58: 2754-2760
5. Ciolino, H. P., Daschner, P. J., Wang, T. T. Y., Yeh, G. C. (1998b) Effect of curcumin on the aryl hydrocarbon receptor and cytochrome P450 1A1 in MCF-7 human breast carcinoma cells. Biochem. Pharmacol. 56: 197-206
6. Ciolino, H. P., Daschner, P. J., Yeh, G. C. (1999) Dietary flavonols quercetin and kaempferol are ligands of the aryl hydrocarbon receptor that affect CYP1A1 transcription differentially. Biochem. J. 340: 715-722
7. Doostdar, H., Burke, M. D., Mayer, R. T. (2000) Bioflavonoids: selective substrates and inhibitors for cytochrome P450 CYP1A and CYP1B1. Toxicology 144: 31-38
8. Garcea, G., Jones, D. J. L., Singh, R., Dennison, A. R., Farmer, P. B., Sharma, R. A., Steward, W. P., Gescher, A. J., Berry, D. P. (2004) Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration. Br. J. Cancer 90: 1011-1015
9. Guengerich, F. P., Chun, Y.-J., Kim, D., Gillam, E. M. J., Shimada, T. (2003) Cytochrome P450 1B1: a target for inhibition in anticarcinogenesis strategies. Mut. Res. 523-524: 173-182
10. Harper, P. A., Riddick, D. S., Okey, A. B. (2006) Regulating the regulator: factors that control levels and activity of the aryl hydrocarbon receptor. Biochem. Pharmacol. 72: 267-279
11. Hartley, D. P., Klaassen, C. D. (2000) Detection of chemical-induced differential expression of rat hepatic cytochrome P450 mRNA transcripts using branched DNA signal amplification technology. Drug Metab. Dispos. 28: 608-616
12. Henderson, M. C., Mirnada, C. L., Stevens, J. F., Deinzer, M. L., Buhler, D. R. (2000) In vitro inhibition of human P450 enzymes by prenylated flavonoids from hops, Humulus lupulus. Xenobiotica 30: 235-251
13. Jaipetch, T., Reutrakul, V., Tuntiwachwuttikul, P., Santisuk, T. (1983) Flavonoids in the black rhizomes of Boesenbergia pandurata. Phytochemistry 22: 625-626
14. Kim, J. H., Stansbury, K. H., Walker, N. J., Trush, M. A., Strickland, P. T., Sutter, T. R. (1998) Metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-diol by human cytochrome P450 1B1. Carcinogenesis 19: 1847-1853
15. Kim, J. H., Sherman, M. E., Curriero, F. C., Guengerich, F. P., Strickland, P. T., Sutter, T. R. (2004) Expression of cytochromes P450 1A1 and 1B1 in human lung from smokers, non-smokers, and ex-smokers. Toxicol. Appl. Pharmacol. 199: 210-219
16. Lee, J.-E., Safe, S. (2000) 3′,4′-Dimethoxyflavone as an aryl hydrocarbon receptor antagonist in human breast cancer cells. Toxicol. Sci. 58: 235-242
17. Lowry, O. H., Rosebrough, N. J., Farr, A. L., Randall, R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275
18. Macdonald, C. J., Ciolino, H. P., Yeh, G. C. (2004) The drug salicylamide is an antagonist of the aryl hydrocarbon receptor that inhibits signal transduction induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Cancer Res. 64: 429-434
19. Manach, C., Donovan, J. L. (2004) Pharmacokinetics and metabolism of dietary flavonoids in humans. Free Radic. Res. 38: 771-785
20. Mizuno, M., Iinuma, M., Ohara, M., Tanaka, T., Iwamasa, M. (1991) Chemotaxonomy of the genus Citrus based on polymethoxyflavones. Chem. Pharm. Bull. 39: 945-949
21. Moorthy, B., Miller, K. P., Jiang, W., Williams, E. S., Kondraganti, S. R., Ramos, K. S. (2003) Role of cytochrome P4501B1 in benzo[a]pyrene bioactivation to DNA-binding metabolites in mouse vascular smooth muscle cells: evidence from 32P-postlabeling for formation of 3-hydroxybenzo[a]pyrene and benzo[a]pyrene-3,6-quinone as major proximate genotoxic intermediates. J. Pharmacol. Exp. Ther. 305: 394-401
22. Murray, G. I., Taylor, M. C., Mcfadyen, M. C. E., Mckay, J. A., Greenlee, W. F., Burke, M. D., Melvin, W. T. (1997) Tumor-specific expression of cytochrome P450 CYPB1. Cancer Res. 57: 3026-3031
23. Murray, G. I., Melvin, W. T., Greenlee, W. F., Burke, M. D. (2001) Regulation, function, and tissue-specific expression of cytochrome P450 CYP1B1. Annu. Rev. Pharmacol. Toxicol. 41: 297-316
24. Palermo, C. M., Westlake, C. A., Gasiewicz, T. A. (2005) Epigallocatechin gallate inhibits aryl hydrocarbon receptor gene transcription through an indirect mechanism involving binding to a 90 kDa heat shock protein. Biochemistry 44: 5041-5052
25. Popravko, S. A., Gurevich, A. I., Kolosov, M. N. (1969) Flavonoid components of propolis. Khimiya Prirodnykh Soedinenii 5: 476-482
26. Port, J. L., Yamaguchi, K., Du, B., De Lorenzo, M., Chang, M., Heerdt, P. M., Kopelovich, L., Marcus, C. B., Altorki, N. K., Subbaramaiah, K., Dannenberg, A. J. (2004) Tobacco smoke induces CYP1B1 in the aerodigestive tract. Carcinogenesis 25: 2275-2281
27. Rheinwald, J. G., Beckett, M. A. (1981) Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultured from human squamous cell carcinomas. Cancer Res. 41: 1657-1663
28. Santos, L. S., Corréa, M. J. C., Campos, L. M. O., Andrade, M. A. (1996) Constituents from the leaves of Virola michelli. Fitoterapia 67: 555-556
29. Shimada, T., Gillam, E. M. J., Sutter, T. R., Strickland, P. T., Guengerich, F. P., Yamazaki, H. (1997) Oxidation of xenobiotics by recombinant human cytochrome P450 1B1. Drug Metab. Dispos. 29: 617-622
30. Tokizane, T., Shiina, H., Igawa, M., Enokida, H., Urakami, S., Kawakami, T., Al, E. (2005) Cytochrome P450 1B1 is overexpressed and regulated by hypomethylation in prostate cancer. Clin. Cancer Res. 11: 5793-5801
31. Tsuji, P. A., Walle, T. (2006) Inhibition of benzo[a]pyrene- activating enzymes and DNA-binding in human bronchial epithelial BEAS-2B cells by methoxylated flavonoids. Carcinogenesis 27: 1579-1585
32. Walgren, R. A., Walle, U. K., Walle, T. (1998) Transport of quercetin and its glucosides across human intestinal epithelial Caco-2 cells. Biochem. Pharmacol. 55: 1721-1727
33. Walle, T. (2004) Absorption and metabolism of flavonoids. Free Radic. Biol. Med. 36: 829-837
34. Walle, T., Walle, U. K., Sedmera, D., Klausner, M. (2006) Benzo[a]pyrene-induced oral carcinogenesis and chemoprevention - studies in bioengineered human tissue. Drug Metab. Dispos. 34: 346-350
35. Walle, T., Ta, N., Kawamori, T., Wen, X., Tsuji, P. A., Walle, U. K. (2007) Cancer chemopreventive properties of orally bioavailable flavonoids - methylated versus unmethylated flavones. Biochem. Pharmacol. 73: 1288-1296
36. Wen, X., Walle, T. (2005) Preferential induction of CYP1B1 by benzo[a]pyrene in human oral epithelial cells: Impact on DNA adduct formation and prevention by polyphenols. Carcinogenesis 26: 1774-1781
37. Wen, X., Walle, T. (2006a) Methylation protects dietary flavonoids from rapid hepatic metabolism. Xenobiotica 36: 387-397
38. Wen, X., Walle, T. (2006b) Methylated flavonoids have greatly improved intestinal absorption and metabolic stability. Drug Metab. Dispos. 34: 1786-1792
39. Wen, X., Walle, T. (2006c) Cytochrome P450 1B1, a biomarker and chemopreventive target for benzo[a]pyrene-initiated human esophageal cancer. Cancer Lett. 246: 109-114
40. Wen, X., Walle, U. K., Walle, T. (2005) 5,7-Dimethoxyflavone down-regulates CYP1A1 expression and benzo[a]pyrene-induced DNA binding in Hep G2 cells. Carcinogenesis 26: 803-809
41. Williamson, G., Manach, C. (2005) Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am. J. Clin. Nutr. 81: 243S-255S
42. Yenjai, C., Prasanphen, K., Daodee, S., Wongpanich, V., Kittakoop, P. (2004) Bioactive flavonoids from Kaempferia parviflora. Fitoterapia 75: 89-92
43. Zhang, S., Qin, C., Safe, S. (2003) Flavonoids as aryl hydrocarbon receptor agonists/antagonists: effects of structure and cell context. Environ. Health Perspect. 111: 1877-1882